DK1083902T3 - Nye galeniske præparatformer af meloxicam til oral administrering - Google Patents
Nye galeniske præparatformer af meloxicam til oral administreringInfo
- Publication number
- DK1083902T3 DK1083902T3 DK99915690T DK99915690T DK1083902T3 DK 1083902 T3 DK1083902 T3 DK 1083902T3 DK 99915690 T DK99915690 T DK 99915690T DK 99915690 T DK99915690 T DK 99915690T DK 1083902 T3 DK1083902 T3 DK 1083902T3
- Authority
- DK
- Denmark
- Prior art keywords
- meloxicam
- oral administration
- galenic formulations
- novel galenic
- novel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98105569A EP0945134A1 (de) | 1998-03-27 | 1998-03-27 | Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation |
| PCT/EP1999/001949 WO1999049867A1 (de) | 1998-03-27 | 1999-03-23 | Neue galenische zubereitungsformen von meloxicam zur oralen applikation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1083902T3 true DK1083902T3 (da) | 2004-03-29 |
Family
ID=8231652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99915690T DK1083902T3 (da) | 1998-03-27 | 1999-03-23 | Nye galeniske præparatformer af meloxicam til oral administrering |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6869948B1 (da) |
| EP (2) | EP0945134A1 (da) |
| JP (1) | JP3639532B2 (da) |
| KR (1) | KR100589299B1 (da) |
| CN (1) | CN1163231C (da) |
| AR (1) | AR016197A1 (da) |
| AT (1) | ATE254920T1 (da) |
| AU (1) | AU762322C (da) |
| BR (1) | BR9909192A (da) |
| CA (1) | CA2326517C (da) |
| DE (1) | DE59907871D1 (da) |
| DK (1) | DK1083902T3 (da) |
| ES (1) | ES2212547T3 (da) |
| HK (1) | HK1034183A1 (da) |
| HU (1) | HUP0101246A3 (da) |
| IL (2) | IL137652A0 (da) |
| NO (1) | NO326852B1 (da) |
| NZ (1) | NZ507382A (da) |
| PL (1) | PL192967B1 (da) |
| PT (1) | PT1083902E (da) |
| TR (1) | TR200002786T2 (da) |
| TW (1) | TWI236914B (da) |
| UY (1) | UY25441A1 (da) |
| WO (1) | WO1999049867A1 (da) |
| ZA (1) | ZA200004178B (da) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5524435B2 (ja) * | 1998-12-01 | 2014-06-18 | ドクター レディーズ ラボラトリーズ リミティド | 新規医薬組成物及びその調製のための方法 |
| AU1548001A (en) | 1999-11-24 | 2001-06-04 | Wakamoto Pharmaceutical Co., Ltd. | Ophthalmic aqueous preparation |
| JP2004506609A (ja) * | 2000-05-26 | 2004-03-04 | ノボ ノルディスク アクティーゼルスカブ | 新たなる医薬組成物及びその調製の為の方法 |
| WO2001091751A1 (en) * | 2000-05-30 | 2001-12-06 | Novo Nordisk A/S | New pharmaceutical composition and the process for its preparation |
| US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
| DE10030345A1 (de) * | 2000-06-20 | 2002-01-10 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen |
| US7120656B1 (en) | 2000-10-04 | 2006-10-10 | Marvell International Ltd. | Movable tap finite impulse response filter |
| SK11802003A3 (sk) * | 2001-02-27 | 2004-06-08 | Ranbaxy Laboratories Limited | Rýchlo rozpustné tablety enzýmového inhibítora cyklooxygenázy-2 |
| EP1250921A1 (en) * | 2001-04-21 | 2002-10-23 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Fast disintegrating meloxicam tablet |
| DE10161077A1 (de) * | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
| EP1348436A1 (en) * | 2002-03-30 | 2003-10-01 | Boehringer Ingelheim International GmbH | Meloxicam suppositories |
| GB0209257D0 (en) * | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
| DE10232113A1 (de) * | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
| DE10250081A1 (de) * | 2002-10-25 | 2004-05-13 | Boehringer Ingelheim Vetmedica Gmbh | Wasserlösliche Meloxicam Granulate |
| US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
| DK3241550T3 (da) | 2002-11-22 | 2020-08-24 | Gruenenthal Gmbh | Anvendelse af (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol til behandling af inflammatoriske smerter |
| US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
| US20100297252A1 (en) | 2003-03-03 | 2010-11-25 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
| CA2519432C (en) * | 2003-03-17 | 2009-06-09 | Japan Tobacco Inc. | Pharmaceutical compositions comprising cetp inhibitors and a water-insoluble concentration-enhancing additive for the treatment of cardiovascular disease |
| KR100620239B1 (ko) * | 2004-01-05 | 2006-09-13 | 신일제약주식회사 | 용해도 및 안정성이 향상된 경구투여용 멜록시캄 고형제조성물 |
| EP1568369A1 (en) * | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
| DE102004021281A1 (de) | 2004-04-29 | 2005-11-24 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
| DE102004030409A1 (de) * | 2004-06-23 | 2006-01-26 | Boehringer Ingelheim Vetmedica Gmbh | Neue Verwendung von Meloxicam in der Veterinärmedizin |
| US20060025408A1 (en) * | 2004-08-02 | 2006-02-02 | Sundaram Venkataraman | Process for the preparation of crystalline form-1 of 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide |
| PT3056492T (pt) | 2004-10-08 | 2021-12-27 | Abbvie Inc | Sal de meglumina e formas cristalinas do mesmo de um fármaco (delafloxacina) |
| HU227359B1 (en) * | 2004-12-18 | 2011-04-28 | Egis Gyogyszergyar Nyilvanosan Mikodi Ruszvunytarsasag | Process for producing meloxicam and meloxicam potassium salt of high purity |
| AU2005313365A1 (en) | 2004-12-06 | 2006-06-15 | Janssen Pharmaceutica N.V. | Oral suspension comprising meloxicam |
| JP5577021B2 (ja) | 2005-02-17 | 2014-08-20 | アボット・ラボラトリーズ | 動物における障害を治療および予防するための薬剤組成物の経粘膜投与 |
| JP2008540644A (ja) * | 2005-07-15 | 2008-11-20 | テバ ファーマシューティカル インダストリーズ リミティド | 新規粒質化方法及びそれから生成される粒質物 |
| BRPI0617208A2 (pt) * | 2005-09-30 | 2011-07-19 | Boehringer Ingelheim Vetmed | preparação farmacêutica contendo meloxicam |
| US7572641B2 (en) | 2005-11-22 | 2009-08-11 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical compositions comprising meloxicam and methods of their preparation |
| EP1965774A2 (en) * | 2005-12-30 | 2008-09-10 | Cogentus Pharmaceuticals, Inc. | Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
| KR100791160B1 (ko) * | 2006-05-30 | 2008-01-02 | 조선대학교산학협력단 | 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물 |
| US20070281927A1 (en) * | 2006-06-06 | 2007-12-06 | Shanthakumar Tyavanagimatt | Anti-inflammatory and analgesic compositions and related methods |
| EP2244712B1 (en) * | 2008-01-22 | 2015-08-05 | Thar Pharmaceuticals Inc. | In vivo studies of crystalline forms of meloxicam |
| TR200809200A1 (tr) | 2008-12-01 | 2009-12-21 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Meloksikam içeren farmasötik formülasyonlar |
| CN102647971B (zh) | 2009-10-12 | 2016-03-16 | 贝林格尔.英格海姆维特梅迪卡有限公司 | 用于包含美洛昔康的组合物的容器 |
| MX2012010077A (es) | 2010-03-03 | 2012-09-12 | Boehringer Ingelheim Vetmed | Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos. |
| US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
| US8791105B2 (en) | 2010-07-14 | 2014-07-29 | Kansas State University Research Foundation | Methods for alleviating chronic pain and improving performance of cattle undergoing dehorning or castration |
| US20170281640A1 (en) * | 2016-04-04 | 2017-10-05 | Productos Maver, S.A. De C.V. | Pharmaceutical Compositions Containing a Muscle Relaxant and a Nonsteroidal Anti-Inflammatory Drugs (NSAID) |
| WO2020095316A1 (en) * | 2018-11-05 | 2020-05-14 | Mylan Laboratories Limited | Meloxicam co-crystals |
| EP3958841A1 (en) | 2019-04-22 | 2022-03-02 | Mylan Specialty L.P. | Meloxicam co-crystal compositions |
| CA3200729A1 (en) | 2020-11-06 | 2022-05-12 | Mylan Laboratories Ltd | Pharmaceutical composition comprising meloxicam |
| CN112587497A (zh) * | 2020-12-25 | 2021-04-02 | 苏州中化药品工业有限公司 | 一种美洛昔康混悬液胶囊剂及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2756113A1 (de) * | 1977-12-16 | 1979-06-21 | Thomae Gmbh Dr K | Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
| IT1207994B (it) | 1986-01-03 | 1989-06-01 | Therapicon Srl | Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche. |
| DE69636413T2 (de) * | 1995-11-13 | 2007-03-29 | North West University | Verabreichungsmedium für analgetische, entzündungshemmende und antipyretische wirkstoffe und pharmazeutische zusammensetzungen enthaltend solches medium und wirkstoffe |
| US6284269B1 (en) * | 1997-08-27 | 2001-09-04 | Hexal Ag | Pharmaceutical compositions of meloxicam with improved solubility and bioavailability |
-
1998
- 1998-03-27 EP EP98105569A patent/EP0945134A1/de not_active Withdrawn
-
1999
- 1999-03-04 TW TW088103316A patent/TWI236914B/zh not_active IP Right Cessation
- 1999-03-23 DK DK99915690T patent/DK1083902T3/da active
- 1999-03-23 HU HU0101246A patent/HUP0101246A3/hu unknown
- 1999-03-23 PT PT99915690T patent/PT1083902E/pt unknown
- 1999-03-23 EP EP99915690A patent/EP1083902B1/de not_active Expired - Lifetime
- 1999-03-23 KR KR1020007010703A patent/KR100589299B1/ko not_active IP Right Cessation
- 1999-03-23 BR BR9909192-5A patent/BR9909192A/pt not_active Application Discontinuation
- 1999-03-23 AU AU34171/99A patent/AU762322C/en not_active Ceased
- 1999-03-23 IL IL13765299A patent/IL137652A0/xx active IP Right Grant
- 1999-03-23 PL PL342988A patent/PL192967B1/pl not_active IP Right Cessation
- 1999-03-23 CN CNB998044687A patent/CN1163231C/zh not_active Expired - Fee Related
- 1999-03-23 JP JP2000540830A patent/JP3639532B2/ja not_active Expired - Lifetime
- 1999-03-23 ES ES99915690T patent/ES2212547T3/es not_active Expired - Lifetime
- 1999-03-23 WO PCT/EP1999/001949 patent/WO1999049867A1/de active IP Right Grant
- 1999-03-23 TR TR2000/02786T patent/TR200002786T2/xx unknown
- 1999-03-23 NZ NZ507382A patent/NZ507382A/en unknown
- 1999-03-23 AT AT99915690T patent/ATE254920T1/de active
- 1999-03-23 CA CA002326517A patent/CA2326517C/en not_active Expired - Lifetime
- 1999-03-23 DE DE59907871T patent/DE59907871D1/de not_active Expired - Lifetime
- 1999-03-24 UY UY25441A patent/UY25441A1/es not_active Application Discontinuation
- 1999-03-26 US US09/277,049 patent/US6869948B1/en not_active Expired - Lifetime
- 1999-03-26 AR ARP990101339A patent/AR016197A1/es not_active Suspension/Interruption
-
2000
- 2000-08-01 IL IL137652A patent/IL137652A/en not_active IP Right Cessation
- 2000-08-16 ZA ZA200004178A patent/ZA200004178B/en unknown
- 2000-09-26 NO NO20004823A patent/NO326852B1/no not_active IP Right Cessation
-
2001
- 2001-07-04 HK HK01104588A patent/HK1034183A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1083902T3 (da) | Nye galeniske præparatformer af meloxicam til oral administrering | |
| DK1674084T3 (da) | Forlænget frigivelse af oral dosissammensætning | |
| NO20020208L (no) | Flytende sammensetninger for oral administrasjon | |
| DK0876131T3 (da) | Sammensætninger til lægemiddelindgivelse til forbedret stabilitet af androgener | |
| EE04799B1 (et) | Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
| NO20020976L (no) | Retarderte, orale, farmasöytiske administreringsformer | |
| ATE296619T1 (de) | Feste orale dosierungsform von simethicon | |
| AR026045A1 (es) | Formulaciones de liberacion prolongada de derivados de eritromocina | |
| DK1448235T3 (da) | Orale, farmaceutiske sammensætninger af 5,8,14-triaza-tetracyclo[10.3.1.0(2,11).0(4.9)]-hexadeca-2(11),3,5,7,9-pentaen med kontrolleret frigivelse | |
| DK1156777T3 (da) | Præparat til oral administration til inhibering af dårlig ånde | |
| NO20033343L (no) | Farmasöytiske doseringsformer av epothiloner for oral administrasjon | |
| CO5590918A2 (es) | Formulaciones | |
| DK1237408T3 (da) | Hæld-på-formuleringer | |
| IS6508A (is) | Lyfjasamsetningar af glycogen fosfórýlasa lötum | |
| NO20021834D0 (no) | Orale formuleringer av anti-tumorforbindelser | |
| NO20015670D0 (no) | Forbedrede farmasöytiske formuleringer | |
| NO20014738L (no) | Tolperisonholdig farmasöytisk preparat for oral administrering | |
| EE200300501A (et) | Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid | |
| FI20000780A (fi) | Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi | |
| DK1331935T3 (da) | Derivater af tryptamin og analoge forbindelser samt farmaceutiske formuleringer deraf | |
| NO996044L (no) | Rapamycinformuleringer for oral administrasjon | |
| DK1216032T3 (da) | Orale formuleringer med kontrolleret frigivelse | |
| DK1071397T3 (da) | Levosimendan-holdige lægemidler til oral indgivelse med kontrolleret frisætning af det aktive middel | |
| NO20003799D0 (no) | Innkorporering av kolesterol-senkende midler i konfektdosisformer | |
| EE05380B1 (et) | FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid |